Navigation Links
Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
Date:9/5/2007

h respect to business conducted by Genta Incorporated. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Forward- looking statements include, without limitation, statements about:

-- the Company's ability to obtain necessary regulatory approval for

Genasense(R) from the U.S. Food and Drug Administration ("FDA") or

European Medicines Agency ("EMEA");

-- the safety and efficacy of the Company's products or product

candidates;

-- the Company's assessment of its clinical trials;

-- the commencement and completion of clinical trials;

-- the Company's ability to develop, manufacture, license and sell its

products or product candidates;

-- the Company's ability to enter into and successfully execute license

and collaborative agreements, if any;

-- the adequacy of the Company's capital resources and cash flow

projections, and the Company's ability to obtain sufficient financing

to maintain the Company's planned operations;

-- the adequacy of the Company's patents and proprietary rights;

-- the impact of litigation that has been brought against the Company and

its officers and directors and any proposed settlement of such

litigation; and

-- the other risks described under Certain Risks and Uncertainties Related

to the Company's Business, as contained in the Company's Annual Report

on Form 10-K and Quarterly Report on Form 10-Q.

The Company does not undertake to update any forward-looking statements. There are a number of factors that could cause actual results and developments to differ materially. For a discussion of those risks and uncertainties, please see the Company's Annual Report on Form 10-K for 2006 and its most recent quarterly report on Form 10-Q.

CONTACT:

For Gen
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. IDM Pharma Presents Preliminary Results from Phase II UVIDEM Melanoma Vaccine Clinical Trial
2. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
3. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
4. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
5. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
6. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
7. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
8. Multiferon Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
9. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 ,, Reportlinker.com announces ... available in its catalogue: ,, Hepatitis ... Forecasts to 2015 ,, http://www.reportlinker.com/p0167309/Hepatitis-B-Vaccines---Pipeline-Analysis-and-Market-Forecasts-to-2015.html ... Analysis and Market Forecasts to 2015 ,, ... analysis specialist,s new report, "Hepatitis B Vaccines ...
(Date:12/15/2009)... Mass., Dec. 15 /PRNewswire-FirstCall/ ... today announced that SDMS Vision Publisher(TM) (v.7.1 SR4), ... Scientific Data Management System (SDMS), a secure electronic ... scientific data to a centralized database and is ... has been certified compliant with the SAFE-BioPharma digital ...
(Date:12/15/2009)... DIEGO, Dec. 15 Safe Life ... developing novel technologies that prevent the spread of ... ramping production of its comfortable, breathable, A400 Series ... address the global shortage of N95 respirators during ... capacity in response to a rapid rise in ...
Breaking Medicine Technology:Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015 7Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 2Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 3Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 4Zargis Cardioscan 28TM 29 Featured on The Early Show on CBS 6515 1Zargis Cardioscan 28TM 29 Featured on The Early Show on CBS 6515 2Zargis Cardioscan 28TM 29 Featured on The Early Show on CBS 6515 3Chronic Pain Trips Up Seniors 62056 1Chronic Pain Trips Up Seniors 62056 2Chronic Pain Trips Up Seniors 62056 3Hard To Treat Diseases 28HTDS 29 Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 62052 1Hard To Treat Diseases 28HTDS 29 Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 62052 2Hard To Treat Diseases 28HTDS 29 Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 62052 3
... the "NEXT" Study Also Showed Arzoxifene Significantly Suppressed ... with OsteoporosisATHENS, Greece, March 23 Eli Lilly ... new data showing arzoxifene, an investigational selective estrogen ... increasing bone mineral density (BMD) in the lumbar ...
... Mass. and NEW YORK, March 20 ... and Nature Publishing Group (NPG) , a ... partnership to facilitate greater scientific collaboration and open ... together to stimulate the involvement of scientists worldwide ...
Other Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation 2InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation 3InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation 4
(Date:12/15/2009)... Indictment of 30 Individuals Charged in Miami, Detroit ... Fraudulent Billing to Medicare ,, WASHINGTON, ... charged in three cities for their alleged roles ... in false Medicare claims as part of the ... Department of Health and Human Services (HHS) Secretary ...
(Date:12/15/2009)... help older adults delay or reverse declining brain ... at the Johns Hopkins Bloomberg School of Public ... researchers found that seniors participating in a youth ... that support cognitive abilities important to planning and ... first of its kind to demonstrate that valuable ...
(Date:12/15/2009)... in teens, study suggests , , TUESDAY, Dec. 15 (HealthDay ... the risk of obstructive sleep apnea, but the same ... Australian researchers have found. , In sleep tests conducted ... were referred for evaluation of snoring and possible obstructive ... 12 and older the risk of obstructive sleep apnea ...
(Date:12/15/2009)... a leading provider of secure USB devices, today launches SafeConsole ... flash drive. The software is designed to provide better usability ... of new features and range of licensing options. , ... ... -- BlockMaster ( www.blockmastersecurity.com ) a leading provider of secure ...
(Date:12/15/2009)... fewer complications, analysis finds, , , TUESDAY, Dec. 15 (HealthDay ... women and their doctors have some options, but new ... procedure is nearly as effective in diagnosing breast cancer ... than the surgical version. , The new analysis, scheduled ... Annals of Internal Medicine , looked over data from ...
Breaking Medicine News(10 mins):Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:For older adults, participating in social service activities can improve brain functions 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 2Health News:BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices 3Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2
... 2006) questions the government over a possible ?300 million drop ... is already// under pressure on several different fronts. ,Under ... ?1 billion would be created for health research, which is ... NHS Research and Development programme. The combined value of the ...
... L. Bates of New Windsor, will be celebrating his 80th ... has another reason to celebrate, he will be presented// with ... the global leader in diabetes research, care and education. This ... 75 years. Apparently, the hotel is commemorating its 80th anniversary. ...
... affects 4.5 million Americans according to the National Institutes of ... $100 billion each year. As the wave of baby boomers ... people with AD will increase, along with the costs for ... to the characteristic pathology of the disease, a new study ...
... pandemic or influenza outbreak, South Australia is coughing up ... said//. The fund would assist in the procurement of ... to fight a potential influenza outbreak. ... uncontrollable, nearly 25% of South Australians could become sick ...
... Wednesday arrested a fake doctor and his wife for allegedly ... near here//. ,Pritam Singh Amarjit Kaur had been carrying ... for couples wanting to get rid of female foetuses. ... working as a medical attendant with them tipped off police, ...
... states that pre-menopausal women who are exposed to second hand ... study that was a collaborative effort by researchers from the ... team of Chinese researchers, was conducted on 14,000 men, pre ... had measured the mineral density of the hipbone and had ...
Other Medicine News:Health News:NHS research under pressure, and could face ?300 million cut, BMA warn 2Health News:Recognition for 75 Years with Type 1 Diabetes!! 2Health News:Recognition for 75 Years with Type 1 Diabetes!! 3Health News:A “Leaky” Blood-Brain Barrier and Alzheimer 2Health News:Second-hand Smoke Could Increase The Risk Of Osteoporosis In Pre-menstrual Women 2
... is based on sequential binding of HCG ... (specific for the *-chain of HCG) immobilized ... for the *-chain of HCG) conjugated to ... step, chromogenic substrate is added and colors ...
For the quantitative determination of Glycohemoglobin in blood....
... storage protein for iron. The ferritin molecule ... of heavy and light subunits, which surrounds ... phosphate [1]. Ferritin is synthesized in the ... with major concentrations found in the liver, ...
...
Medicine Products: